{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:17:37Z","timestamp":1762377457959,"version":"3.41.2"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["63631 0011"],"award-info":[{"award-number":["63631 0011"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Psychiatric comorbidities have a significant impact on the course of illness in patients with schizophrenia spectrum disorders. To accurately predict outcomes for individual patients using computerized prognostic models, it is essential to consider these comorbidities and their influence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In our study, we utilized a multi-modal deep learning architecture to forecast symptomatic remission, focusing on a multicenter sample of patients with first-episode psychosis from the OPTiMiSE study. Additionally, we introduced a counterfactual model explanation technique to examine how scores on the Mini International Neuropsychiatric Interview (MINI) affected the likelihood of remission, both at the group level and for individual patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our findings at the group level revealed that most comorbidities had a negative association with remission. Among them, current and recurrent depressive disorders consistently exerted the greatest negative impact on the probability of remission across patients. However, we made an interesting observation: current suicidality within the past month and substance abuse within the past 12\u2009months were associated with an increased chance of remission in patients. We found a high degree of variability among patients at the individual level. Through hierarchical clustering analysis, we identified two subgroups: one in which comorbidities had a relatively limited effect on remission (approximately 45% of patients), and another in which comorbidities more strongly influenced remission. By incorporating comorbidities into individualized prognostic prediction models, we determined which specific comorbidities had the greatest impact on remission at both the group level and for individual patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These results highlight the importance of identifying and including relevant comorbidities in prediction models, providing valuable insights for improving the treatment and prognosis of patients with psychotic disorders. Furthermore, they open avenues for further research into the efficacy of treating these comorbidities to enhance overall patient outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1237490","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T16:57:51Z","timestamp":1697129871000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Revealing the impact of psychiatric comorbidities on treatment outcome in early psychosis using counterfactual model explanation"],"prefix":"10.3389","volume":"14","author":[{"given":"Violet","family":"van Dee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mostafa","family":"Kia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Winter-van Rossum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 S.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiepke","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo G.","family":"Schnack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/J.PSYCHRES.2013.05.013","article-title":"Psychiatric comorbidity among adults with schizophrenia: a latent class analysis","volume":"210","author":"Tsai","year":"2013","journal-title":"Psychiatry Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/J.JAD.2020.01.141","article-title":"Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: systematic review and meta-analysis","volume":"266","author":"Hunt","year":"2020","journal-title":"J Affect Disord"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.PSYCHRES.2013.07.030","article-title":"Anxiety comorbidity in schizophrenia","volume":"210","author":"Braga","year":"2013","journal-title":"Psychiatry Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/SCHBUL\/SBAA153","article-title":"Comorbid major depressive disorder in schizophrenia: a systematic review and Meta-analysis","volume":"47","author":"Etchecopar-Etchart","year":"2021","journal-title":"Schizophr Bull"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/ACPS.12948","article-title":"Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia","volume":"139","author":"Arican","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/FPSYT.2019.00078","article-title":"Autistic symptoms in schizophrenia Spectrum disorders: a systematic review and Meta-analysis","volume":"10","author":"Crescenzo","year":"2019","journal-title":"Front Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/S41588-022-01245-2","article-title":"Exploring the genetic overlap between twelve psychiatric disorders","volume":"54","author":"Romero","year":"2022","journal-title":"Nat Genet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/J.JPSYCHIRES.2006.06.008","article-title":"Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study","volume":"40","author":"Sim","year":"2006","journal-title":"J Psychiatr Res"},{"key":"ref9","first-page":"115","article-title":"Thirty-day hospital readmission for Medicaid enrollees with schizophrenia: the role of local health care systems","volume":"18","author":"Busch","year":"2015","journal-title":"J Ment Health Policy Econ"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/J.SCHRES.2019.04.011","article-title":"Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling","volume":"208","author":"van Rooijen","year":"2019","journal-title":"Schizophr Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/SCHBUL\/SBX131","article-title":"Risk factors for suicidality in patients with schizophrenia: a systematic review, Meta-analysis, and Meta-regression of 96 studies","volume":"44","author":"Cassidy","year":"2018","journal-title":"Schizophr Bull"},{"volume-title":"Relationship between obsessive compulsive symptomatology and severity of psychotic symptoms in schizophrenia: Meta-analysis and meta-regression analysis","year":"2023","author":"Cunill","key":"ref12"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2016.05.004","volume-title":"A systematic review on comorbid post-traumatic stress disorder in schizophrenia","author":"Seow","year":"2016"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/J.SCHRES.2019.12.011","article-title":"Depressive symptoms during first episode psychosis and functional outcome: a systematic review and Meta-analysis","volume":"218","author":"McGinty","year":"2020","journal-title":"Schizophr Res"},{"key":"ref15","first-page":"173","article-title":"Childhood Trauma, Depression and Negative Symptoms Are Independently Associated with Impaired Quality of Life in Schizophrenia. Results from the National Face-Sz Cohort","volume-title":"Schizophr Res","author":"Andrianarisoa","year":"2017"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/0004867414525838","article-title":"Systematic Meta-analysis of outcomes associated with psychosis and co-morbid substance use","volume":"48","author":"Large","year":"2014","journal-title":"Aust N Z J Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/J.SCHRES.2017.04.016","article-title":"The link between schizophrenia and substance use disorder: a unifying hypothesis","volume":"194","author":"Khokhar","year":"2017","journal-title":"Schizophr Res"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2018.2165","volume-title":"Prediction models of functional outcomes for individuals in the clinical high-risk state for psychosis or with recent-onset depression: A multimodal, multisite machine learning analysis","author":"Koutsouleris","year":"2018"},{"year":"2020","author":"Mothilal","key":"ref19"},{"volume-title":"Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study","year":"2018","author":"Kahn","key":"ref20"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/APPI.AJP.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1101\/2023.07.05.23292252","article-title":"Psychosis prognosis predictor: a continuous and uncertainty-aware prediction of treatment outcome in first-episode psychosis","author":"van Opstal","year":"2023","journal-title":"medRxiv"},{"key":"ref23","first-page":"369","article-title":"Causal Inference and Counterfactual Prediction in Machine Learning for Actionable Healthcare","volume-title":"Nat Mach Intell","author":"Prosperi","year":"2020"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1214\/AOMS\/1177730491","article-title":"On a test of whether one of two random variables is stochastically larger than the other","volume":"18","author":"Mann","year":"1947","journal-title":"Ann Math Stat Inst Math Stat"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-3-319-21903-5_8","article-title":"Hierarchical Clustering","volume-title":"Introduction to Hpc with Mpi for Data Science","author":"Nielsen","year":"2016"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/J.SCHRES.2006.07.004","article-title":"Physical comorbidity, insight, quality of life and global functioning in first episode schizophrenia: a 24-month, longitudinal outcome study","volume":"88","author":"Sim","year":"2006","journal-title":"Schizophr Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.schres.2023.02.024","article-title":"Systematic Review and Meta-Analysis on Predictors of Prognosis in Patients with Schizophrenia Spectrum Disorders: An Overview of Current Evidence and a Call for Prospective Research and Open Access to Datasets","volume":"254","author":"van Dee","year":"2023","journal-title":"Schizophr Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.schres.2016.08.009","article-title":"Lifetime Suicide Intent, Executive Function and Insight in Schizophrenia and Schizoaffective Disorders","volume":"178","author":"Verma","year":"2016","journal-title":"Schizophr Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55070361","article-title":"Suicide in Schizophrenia: An Educational Overview","volume":"55","author":"Sher","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"ref30","first-page":"490","article-title":"Symptomatic Remission and Social\/Vocational Functioning in Outpatients with Schizophrenia: Prevalence and Associations in a Cross-Sectional Study","volume-title":"European Psychiatry","author":"San","year":"2007"},{"key":"ref31","first-page":"210","article-title":"Shorter Hospital Stays and More Rapid Improvement among Patients with Schizophrenia and Substance Disorders","volume-title":"Psychiatr Serv","author":"Ries","year":"2000"},{"key":"ref32","first-page":"84","article-title":"Substance-Related Exogenous Psychosis: A Postmodern Syndrome","volume-title":"CNS Spectr","author":"Martinotti","year":"2021"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4088\/JCP.v69n0304","article-title":"Substance-induced psychosis: a diagnostic conundrum","volume":"69","author":"Mathias","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/SCHBUL\/SBZ102","article-title":"Transition of substance-induced, brief, and atypical psychoses to schizophrenia: a systematic review and Meta-analysis","volume":"46","author":"Murrie","year":"2020","journal-title":"Schizophr Bull"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/J.EURPSY.2017.02.484","article-title":"Chronic physical illnesses in patients with schizophrenia Spectrum disorders are independently associated with higher rates of psychiatric Rehospitalization; a cross-sectional study in Croatia","volume":"43","author":"Filipcic","year":"2017","journal-title":"Eur Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1237490\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T16:57:59Z","timestamp":1697129879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1237490\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":35,"alternative-id":["10.3389\/fpsyt.2023.1237490"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1237490","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"article-number":"1237490"}}